NCT02513563 AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02510781 A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs Status UNKNOWN Phase PHASE2
NCT02509286 Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02501954 Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol Status COMPLETED Phase PHASE3
NCT02499770 Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT02492867 A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase NA
NCT02489903 RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) Status COMPLETED Phase PHASE2
NCT02488967 Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02487849 HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma Status WITHDRAWN Phase PHASE2
NCT02483104 Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02477826 An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT02471911 KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT02470585 Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status TERMINATED Phase PHASE3
NCT02469116 Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma Status TERMINATED Phase PHASE2
NCT02467907 Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer Status COMPLETED Phase PHASE2
NCT02455245 A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02446652 Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer Status WITHDRAWN Phase PHASE3
NCT02446600 Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02445391 Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02437812 Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma Status UNKNOWN Phase PHASE2